Dorsey v. Colgate Palmolive Company

District Court, S.D. New York·Decided December 23, 2024·No. 7:23-cv-01426·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK --------------------------------------------------------------x ARNOLD THOMAS, on behalf of himself and : all others similarly situated, : Plaintiff, : OPINION AND ORDER v. : : 23 CV 1426 (VB) COLGATE-PALMOLIVE COMPANY, : Defendant. : --------------------------------------------------------------x

Briccetti, J.: Plaintiff Arnold Thomas brings this putative class action against defendant Colgate- Palmolive Company (“Colgate”). Plaintiff alleges defendant negligently manufactured, marketed, and sold Fabuloso-branded cleaning products (“Fabuloso”) that were contaminated with bacteria, harming plaintiff and others who purchased and used Fabuloso. Now pending is defendant’s motion to strike plaintiff’s class allegations pursuant to Rule 23 of the Federal Rules of Civil Procedure. (Doc. #28). For the reasons set forth below, the motion is DENIED. The Court has subject matter jurisdiction pursuant to 28 U.S.C. § 1332(d). BACKGROUND The following background is drawn from the amended class action complaint. (Doc. #18 (“Am. Compl.”). In deciding the pending motion, the Court accepts as true all well-pleaded factual allegations in the amended complaint and draws all reasonable inferences in plaintiff’s favor. Defendant is a New York corporation that manufactures numerous consumer products, including Fabuloso. Defendant markets Fabuloso as safe to use on an array of household surfaces. On February 8, 2023, defendant recalled 4.9 million bottles of Fabuloso produced between December 14, 2022, and January 23, 2023, one million of which had been released for sale to the public in the United States. Defendant issued the recall because “a preservative was not added at the intended levels during manufacturing,” creating the “risk of bacteria growth in

the recalled products.” (Am. Compl. ¶¶ 20–21). That error left the affected Fabuloso bottles susceptible to contamination by the Pseudomonas species bacteria—a type of bacteria that can “enter the body if inhaled, through the eyes, or through a break in the skin” and cause “serious infection that may require medical treatment,” especially for “people with weakened immune systems, external medical devices, or underlying lung conditions.” (Id. at ¶ 21). Responding to the recall, the U.S. Consumer Product Safety Commission (“CPSC”) advised consumers to stop using Fabuloso immediately. Plaintiff purchased a Fabuloso bottle, included under defendant’s recall, allegedly containing pseudomonas. After using the product, plaintiff asserts he suffered “significant abdominal pain, diarrhea, dehydration, sores[,] and symptoms and injuries commonly associated

with a Pseudomonas infection.” (Am. Compl. ¶ 27). He sought medical treatment, and his treating medical professional allegedly informed plaintiff “she believed his injuries were caused by Pseudomonas.” (Id.). Plaintiff now brings putative class action claims for products liability and negligence against defendant. He seeks to represent a proposed class of “all consumers who purchased any of the contaminated [Fabuloso] Products in the United States during the Class Period and were physically injured after using the Products.” (Am. Compl. ¶ 33).1

1 Plaintiff’s deceptive advertising claim, asserted in the original complaint (Doc. #1), was not included in the amended complaint. DISCUSSION I. Standard of Review To qualify for class certification, a plaintiff must demonstrate by a preponderance of the evidence that the putative class meets the four requirements set forth in Rule 23(a): (1) the class is so numerous that joinder of all members is impracticable; (2) there are questions of law or fact common to the class; (3) the claims or defenses of the representative parties are typical of the claims or defenses of the class; and (4) the representative parties will fairly and adequately protect the interests of the class.

Fed. R. Civ. P. 23(a); see Wal-Mart Stores, Inc. v. Dukes, 564 U.S. 338, 345 (2011).2 The Second Circuit also requires a plaintiff to demonstrate compliance with a fifth requirement respecting class ascertainability. In re Initial Pub. Offerings Sec. Litig., 471 F.3d 24, 30 (2d Cir. 2006). If the plaintiff meets these five criteria, he or she must also demonstrate by a preponderance of the evidence that the proposed class satisfies “at least one of the three requirements listed in Rule 23(b).” Walmart Stores, Inc. v. Dukes, 564 U.S. at 345. Rule 23 allows courts to “require that the pleadings be amended to eliminate allegations about representation of absent persons.” Fed. R. Civ. P. 23(d)(1)(D). Typically, a court makes such a decision after the plaintiff moves for class certification and class discovery has concluded, but “a party may move to strike class claims even before discovery.” Kassman v. KPMG, LLP, 925 F. Supp. 2d 453, 462 (S.D.N.Y. 2013). Motions to strike class allegations may be granted “where they address issues separate and apart from the issues that will be decided on a class certification motion, or where the movant demonstrates that it would be impossible to certify the alleged class regardless of the

2 Unless otherwise indicated, case quotations omit all internal citations, quotation marks, footnotes, and alterations. facts the plaintiff may be able to obtain during discovery.” Staubitz v. Arthrex, Inc., 2024 WL 4350669, at *2 (E.D.N.Y. Sept. 29, 2024). “In determining whether it would be impossible to certify a class, courts in this circuit generally look to whether the facts alleged in the complaint plausibly support certification.” Id.

As a general matter, the Second Circuit has cautioned against dismissing class allegations without “the benefit” of a plaintiff’s motion to certify “and the evidence relevant to that motion.” Parker v. Time Warner Ent. Co., L.P., 331 F.3d 13, 15 (2d Cir. 2003). Motions to strike are thus “generally looked upon with disfavor and a motion to strike class allegations is even more disfavored because it requires a reviewing court to preemptively terminate the class aspects of litigation, solely on the basis of what is alleged in the complaint and before plaintiffs are permitted to complete the discovery to which they would otherwise be entitled on questions of class certification.” Chen-Oster v. Goldman Sachs & Co., 877 F. Supp. 2d 113, 117 (S.D.N.Y. 2012). As such, “courts in this Circuit have frequently found that a determination of whether Rule 23 requirements are met is more properly deferred to the class certification stage, when a

Free access — add to your briefcase to read the full text and ask questions with AI

Dorsey v. Colgate Palmolive Company, (S.D.N.Y. 2024).

Dorsey v. Colgate Palmolive Company (Dorsey v. Colgate Palmolive Company) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Amchem Products, Inc. v. Windsor
521 U.S. 591 (Supreme Court, 1997)
Wal-Mart Stores, Inc. v. Dukes
131 S. Ct. 2541 (Supreme Court, 2011)
Parker v. Time Warner Entertainment Co., L.P.
331 F.3d 13 (Second Circuit, 2003)
Barrus v. Dick's Sporting Goods, Inc.
732 F. Supp. 2d 243 (W.D. New York, 2010)
Talarico v. Port Auth. of N.Y. & N.J.
367 F. Supp. 3d 161 (S.D. Illinois, 2019)
Miles v. Merrill Lynch & Co.
471 F.3d 24 (Second Circuit, 2006)
Chen-Oster v. Goldman, Sachs & Co.
877 F. Supp. 2d 113 (S.D. New York, 2012)
Kassman v. KPMG LLP
925 F. Supp. 2d 453 (S.D. New York, 2013)
Benner v. Becton Dickinson & Co.
214 F.R.D. 157 (S.D. New York, 2003)
In re Fosamax Products Liability Litigation
248 F.R.D. 389 (S.D. New York, 2008)
Pagan v. Abbott Laboratories, Inc.
287 F.R.D. 139 (E.D. New York, 2012)